Cargando…
Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani
Visceral leishmaniasis (VL) is associated with treatment complications due to the continued growth of resistant parasites toward currently available pathogen-directed therapeutics. To limit the emergence and combat resistant parasites there is a need to develop new anti-leishmanial drugs and alterna...
Autores principales: | Zahid, M. Shamim Hasan, Johnson, Monica M., Tokarski, Robert J., Satoskar, Abhay R., Fuchs, James R., Bachelder, Eric M., Ainslie, Kristy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731340/ https://www.ncbi.nlm.nih.gov/pubmed/31493763 http://dx.doi.org/10.1016/j.ijpddr.2019.08.004 |
Ejemplares similares
-
Ly6C(hi) inflammatory monocytes promote susceptibility to Leishmania donovani infection
por: Terrazas, Cesar, et al.
Publicado: (2017) -
Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance
por: Zheng, Zhiwan, et al.
Publicado: (2020) -
Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen
por: Lafuse, William P., et al.
Publicado: (2013) -
Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes
por: Boitz, Jan M., et al.
Publicado: (2016) -
Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)